A pharmaceuticals health care company.
Development of reauthorizing legislation implementing the Prescription Drug User Fee Act (PDUFA) and Medical Device User Fee Act agreements and related issues.
Federal legislative efforts to enhance the security and integrity of the domestic pharmaceutical distribution system. H.R. 452: Medicare Decisions Accountability Act.
Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program.
H.R. 3497: Moddern Cures Act as it relates to reimbursement of diagnostics. H.R. 5: Help Efficient, Accessible, Low-cost Timely Healthcare Act.
H.R. 452: Medicare Decisions Accountability Act. H. Con. Res. 112: FY 2013 Budget Resolution.
Education regarding the importance of maintaining current law as it relates to biosimilars and opposing efforts in the President's Budget to shorten the term of data exclusivity for innovator biologics. H.R. 436: Protect Medical Innovation Act.
Monitoring H.R. 3630: Middle Class Tax Relief and Job Creation Act.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX